We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Overcoming Challenges in Biopharma: Transformational Innovation is Key

Article   Jan 07, 2019 | by Lisa Sapp (Biopharma Market Manager, Agilent Technologies) and Ning Tang (Biopharma Segment Marketing Manager, Agilent Technologies)

 
Overcoming Challenges in Biopharma: Transformational Innovation is Key
 
 
 

RELATED ARTICLES

Uncovering the Secrets of the Breast Cancer Epigenome

Article

The epigenome plays a crucial role in the development of breast cancer. This exciting and rapidly evolving area of research holds great promise for new interventions – from prevention through to personalized treatment.

READ MORE

It’s in the Water: Antimicrobial Contamination and the Environment

Article

It is hard to imagine a world without antimicrobials. Unfortunately, the lifecycle of an antimicrobial does not end with the human or animal to which it was administered, posing challenges for their removal from the environment.

READ MORE

Cell Culture Evolution – A Revolution for Drug Discovery

Article

Two-dimensional cell cultures have played a role in the drug discovery and development process for decades, however in recent years three-dimensional (3D) cell culture has taken center stage. Here we take a look at the evolution of cell culture, the rise of 3D, and how the industry’s shift from “static” to “fluidic” is inspiring the next generation of in vitro models.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cancer Research Cell Science Diagnostics Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE